- Home
- LGCY vs CLYM Comparison
LGCY vs CLYM Comparison
Compare LGCY & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGCY
- CLYM
- Stock Information
- Founded
- LGCY 2009
- CLYM 2018
- Country
- LGCY United States
- CLYM United States
- Employees
- LGCY N/A
- CLYM N/A
- Industry
- LGCY
- CLYM
- Sector
- LGCY
- CLYM
- Exchange
- LGCY NYSE
- CLYM NYSE
- Market Cap
- LGCY 89.1M
- CLYM 85.8M
- IPO Year
- LGCY 2024
- CLYM 2021
- Fundamental
- Price
- LGCY $9.04
- CLYM $1.18
- Analyst Decision
- LGCY Strong Buy
- CLYM
- Analyst Count
- LGCY 2
- CLYM 0
- Target Price
- LGCY $10.65
- CLYM N/A
- AVG Volume (30 Days)
- LGCY 63.4K
- CLYM 145.4K
- Earning Date
- LGCY 05-15-2025
- CLYM 05-14-2025
- Dividend Yield
- LGCY N/A
- CLYM N/A
- EPS Growth
- LGCY 21.53
- CLYM N/A
- EPS
- LGCY 0.62
- CLYM N/A
- Revenue
- LGCY $58,970,210.00
- CLYM N/A
- Revenue This Year
- LGCY $33.77
- CLYM N/A
- Revenue Next Year
- LGCY $24.88
- CLYM N/A
- P/E Ratio
- LGCY $14.53
- CLYM N/A
- Revenue Growth
- LGCY 37.92
- CLYM N/A
- 52 Week Low
- LGCY $3.60
- CLYM $1.05
- 52 Week High
- LGCY $10.37
- CLYM $9.58
- Technical
- Relative Strength Index (RSI)
- LGCY N/A
- CLYM N/A
- Support Level
- LGCY N/A
- CLYM N/A
- Resistance Level
- LGCY N/A
- CLYM N/A
- Average True Range (ATR)
- LGCY 0.00
- CLYM 0.00
- MACD
- LGCY 0.00
- CLYM 0.00
- Stochastic Oscillator
- LGCY 0.00
- CLYM 0.00
About LGCY LEGACY EDUCATION INC
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.